Last updated: May 11, 2023
Sponsor: Hospices Civils de Lyon
Overall Status: Active - Recruiting
Phase
N/A
Condition
Posterior Uveitis
Treatment
Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum.
Clinical Study ID
NCT05774496
69HCL22_1041
2022-A02496-37
Ages 21-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Being a woman
- Born before March 2022
- Suffering from congenital toxoplamosis
Exclusion
Exclusion Criteria:
- Refusal to give informed consent
- Any condition that would limit the ability of the patient to give consent
- Psychiatric cares
- To be deprived of liberty
- To be under administrative supervision
Study Design
Total Participants: 193
Treatment Group(s): 1
Primary Treatment: Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum.
Phase:
Study Start date:
May 10, 2023
Estimated Completion Date:
May 31, 2024
Connect with a study center
Service de parasitologie et mycologie médicale
Lyon, 69004
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.